Showing results (331-340 of 338) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 338 results.
Journal of Neurosurgery|February 6, 1998
Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhageJ P Elliott, D W Newell, D J Lam, et al.
Restorative Neurology and Neuroscience|May 10, 2011
Intraventricular encapsulated calf adrenal chromaffin cells: viable for at least 500 days in vivo without detectable adverse effects on behavioral/cognitive function or host immune sensitization in ratsM D Lindner, M A Plone, B Frydel, et al.
The Journal of Trauma|April 1, 2000
Clinical measurement, statistical analysis, and risk-benefit: controversies from trials of spinal injuryM B Bracken, E F Aldrich, D L Herr, et al.
Anti-Cancer Drugs|August 1, 1997
An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervixA P Kudelka, R Winn, C L Edwards, et al.
Cell Transplantation|October 23, 1997
Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primatesT Subramanian, D F Emerich, R A Bakay, et al.
Plos One|January 25, 2021
Development of a porcine model of phenylketonuria with a humanized R408W mutation for gene editingRobert A Kaiser, Daniel F Carlson, Kari L Allen, et al.
JAMA|May 28, 1997
Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury StudyM B Bracken, M J Shepard, T R Holford, et al.
Journal of Neurosurgery|November 17, 1998
Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trialM B Bracken, M J Shepard, T R Holford, et al.
Pageof 34